|
"Everyone here should check the Yahoo Finance board for Sellas. This was the very first guy to speak about Merck & Sellas working together and we got news about it immediately after he started talking about it. People there seem to think he knows someone. Either way, this is interesting and I thought it was worth a share: " " Key things to look at. .35 in a little less than 3 weeks, Then FDA announcement. A sharp rise to low 1.27 or a mid 3.25 or a high 4.86. I choose low because that is where this stock trends. A secondary announcement by the company to no longer hold the meeting to RS . Rise to a low of 4.13 a share. Half way through trials with Merck, an offer should be made. Then we will see about 17.50 a share. That is all by January. So sit tight on your shares. " Sieht gut aus, drüben reden sie schon vom Verdoppler am Montag. Schönes Wochenende! |
|
| aus der Diskussion: | Sellas Life Sciences Group (ehemals Galena Biopharma) |
| Autor (Datum des Eintrages): | qsand (02.08.19 22:33:35) |
| Beitrag: | 2,562 von 2,941 (ID:61165247) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |